Rare diseases
Investigational molecules
Locations
Freiburgstrasse 18, 3010
Research activity includes acute ischemic stroke care, with interest in patients who have residual occlusion after mechanical thrombectomy and in those receiving intravenous thrombolysis despite recent direct oral anticoagulant use. The clinical focus extends to improving neurological recovery and treatment safety in complex stroke presentations.
Additional interest lies in optimizing reperfusion strategies when standard treatment pathways are constrained by prior anticoagulant exposure or incomplete vessel reopening.
Insel Gruppe AG runs clinical trials in conditions such as Ischaemic stroke, Atrial fibrillation, Acute coronary syndrome, Chronic coronary syndrome, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Austria
BelgiumAustriaBelgiumAustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
